Abstract
Combining normal-phase HPLC separation and tandem mass spectrometric detection, using an ion-spray HPLC-MS interface, a quantitative method for acyl-platelet activating factor (acyl-PAF), platelet-activating factor (PAF) and related phospholipids was developed. Mass spectra, positive ions, showed intense [M+H]+ ions; collision-induced dissociation of protonated molecular ions gave characteristic daughter ions corresponding to the polar head. Detection limits of 0.1-0.3 ng injected were obtained by multiple reaction monitoring. Samples of human endothelial cells treated with compounds modulating the levels of acyl-PAF and PAF have been analyzed by the present technique, proving that this approach is suitable for biochemical studies.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cells, Cultured
-
Chromatography, High Pressure Liquid
-
Endothelium, Vascular / chemistry
-
Endothelium, Vascular / cytology
-
Humans
-
Linear Models
-
Lysophosphatidylcholines / analysis
-
Lysophosphatidylcholines / chemistry
-
Mass Spectrometry
-
Phospholipid Ethers / analysis
-
Phospholipid Ethers / chemistry
-
Phospholipids / analysis*
-
Phospholipids / chemistry
-
Platelet Activating Factor / analogs & derivatives*
-
Platelet Activating Factor / analysis*
-
Platelet Activating Factor / chemistry
-
Reference Standards
-
Umbilical Veins
Substances
-
1-acyl-2-acetyl-sn-glycero-3-phosphocholine
-
Lysophosphatidylcholines
-
Phospholipid Ethers
-
Phospholipids
-
Platelet Activating Factor
-
CV 3988